30 completed, 2 active not recruiting, 2 recruiting, 2 unknown. 38 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 38 | Completed 30, Active not recruiting 2, Recruiting 2, Unknown 2, Not yet recruiting 1, Withdrawn 1 |
Follow Meningococcal Infections: new trials by email Literature Review of Meningococcal Infections trials Research Report on Meningococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-center, Open-label Study: Immunogenicity and Safety Observation After Vaccination With ACYW135 Meningococcal Polysaccharide Vaccine in Junior High School Students Aged 13-15 Years MPSV-ACYW - Meningococcal Disease; Meningococcal Meningitis | Phase 4 | Not yet recruiting | Zhejiang Provincial Center for Disease Control and Prevention | 200 | 2026-10-20 | 2026-10-21 |
| Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons Serogroup B meningococal vaccine - Meningococcal Meningitis, Serogroup B, Transgender Persons | Phase 4 | Recruiting | University Ghent | 250 | 2025-01-31 | 2026-01-20 |
| Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants MCV4 - Epidemic Meningitis | Phase 4 | Completed | CanSino Biologics Inc. | 3011 | 2024-06-12 | 2026-08-13 |
| A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age rMenB+OMV NZ - Meningitis, Meningococcal | Phase 4 | Active not recruiting | GlaxoSmithKline | 50 | 2023-11-10 | 2026-04-06 |
| Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) MCV4 - Epidemic Meningitis | Phase 4 | Active not recruiting | CanSino Biologics Inc. | 660 | 2023-09-20 | 2026-03-04 |
| Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV Neisseria meningitidis oligosaccharide conjugate vaccine and recombinant protein-based vaccine, 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine - Hiv, Meningococcal Infections | Phase 4 | Recruiting | Thomas Benfield | 55 | 2021-04-28 | 2021-05-06 |
| A Study to Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years Yuxi Walvax MPV ACYW® vaccine, Sanofi Pasteur Menactra® vaccine - Neisseria Meningitides Meningitis | Phase 4 | Completed | Walvax Biotechnology Co., Ltd. | 260 | 2020-12-23 | 2023-07-07 |
| Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018 Ciprofloxacin - Meningitis, Meningococcal | Phase 4 | Withdrawn | Epicentre | 2019-03-01 | 2019-08-14 | |
| Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population Bexsero® (meningitis B vaccine), Menveo® (meningitis ACWY vaccine) - Hiv, Meningitis, Meningococcal | Phase 4 | Unknown | St George's, University of London | 55 | 2019-02-21 | 2019-04-10 |
| Adolescent MenACWY Booster Study MenACWY-CRM, MenACWY-DT, MenACWY-TT - Meningococcal Disease, Invasive | Phase 4 | Completed | Canadian Immunization Research Network | 244 | 2018-09-20 | 2022-03-11 |
| A Sourcing Study to Collect Human Blood Samples From Healthy Adults rMenB+OMV NZ vaccine, Meningococcal Groups A, C, W and Y Conjugate Vaccine (MenACWY) - Meningitis, Meningococcal | Phase 4 | Completed | GlaxoSmithKline | 1021 | 2018-03-08 | 2023-07-17 |
| Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B 4CMenB Vaccine - Prematurity, Vaccination | Phase 4 | Completed | St George's, University of London | 136 | 2017-08-01 | 2020-12-01 |
| Ciprofloxacin for the Prevention of Meningococcal Meningitis Ciprofloxacin - Meningitis, Meningococcal | Phase 4 | Completed | Epicentre | 300 | 2017-04-22 | 2018-02-08 |
| South Australian Meningococcal B Vaccine Herd Immunity Study Licensed 4CMenB vaccine - Meningococcal Disease | Phase 4 | Completed | University of Adelaide | 34489 | 2017-04-01 | 2019-07-02 |
| Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine - Meningitis, Meningococcal Meningitis | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 1311 | 2016-07-21 | 2022-04-25 |
| Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine - Meningitis, Meningococcal Meningitis | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 110 | 2015-12-01 | 2016-11-07 |
| Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate - Meningitis, Meningococcal Meningitis | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 60 | 2015-10-20 | 2017-11-06 |
| Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations MenACWY - Infections, Meningococcal | Phase 4 | Completed | GlaxoSmithKline | 128 | 2015-07-13 | 2019-06-27 |
| Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba) Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals) - Meningococcal Infections | Phase 4 | Completed | UCSF Benioff Children's Hospital Oakland | 18 | 2015-01-01 | 2021-02-02 |
| Hepatitis B Vaccination in Infants Menjugate, Menitorix, NeisVac-C - Meningococcal Disease, Pneumococcal Disease | Phase 4 | Completed | Public Health England | 300 | 2013-07-01 | 2020-10-01 |
Showing 20 of 38. Sign in to see all of them.
Meningitis, Meningococcal (16) · Meningitis (15) · Pneumococcal Infections (5) · Tetanus (4) · Whooping Cough (4) · Diphtheria (3) · Acquired Immunodeficiency Syndrome (2) · Coitus (1) · HIV Infections (1) · Haemophilus Infections (1) · Hepatitis B (1) · Neoplasm Metastasis (1) · Premature Birth (1) · Toxemia (1)
Bacterial Infections (38) · Bacterial Infections and Mycoses (38) · Gram-Negative Bacterial Infections (38) · Infections (38) · Neisseriaceae Infections (38) · Nervous System Diseases (24) · Neuroinflammatory Diseases (24) · Central Nervous System Bacterial Infections (16) · Central Nervous System Diseases (16) · Central Nervous System Infections (16) · Meningitis, Bacterial (16) · Meningitis (9) · Gram-Positive Bacterial Infections (8) · Streptococcal Infections (5)
Meningococcal Vaccines (12) · 4CMenB vaccine (6) · serogroup C meningococcal conjugate vaccine (3) · Ciprofloxacin (2) · MenACWY (2) · PsACWY vaccine (2) · 13-valent pneumococcal vaccine (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · MenACWY-CRM vaccine (1) · MenB-FHbp vaccine (1) · MenC-CRM vaccine (1) · Polysaccharides (1) · Sodium Chloride (1) · Tetanus Toxoid (1) · adacel (1)
Sanofi Pasteur, a Sanofi Company (8) · GlaxoSmithKline (6) · Epicentre (3) · Public Health England (3) · CanSino Biologics Inc. (2) · Novartis (2) · St George's, University of London (2) · Canadian Immunization Research Network (1) · Centro Superior de Investigación en Salud Publica (1) · Chiron Corporation (1) · Novartis Vaccines (1) · Thomas Benfield (1) · UCSF Benioff Children's Hospital Oakland (1) · University Ghent (1) · University of Adelaide (1)
United Kingdom (7) · United States (7) · South Korea (4) · China (3) · Australia (2) · Germany (2) · Niger (2) · Philippines (2) · Belgium (1) · Canada (1) · Denmark (1) · Italy (1) · Japan (1) · Lebanon (1) · Mali (1)
Elizabeth Coates, PhD (2) · Andrew J Pollard, BA, MBBS, FRCPCH, PhD (1) · Andrew J. Pollard, MBBS, FRCPCH, PhD (1) · Catherine Cosgrove, MBBS PhD (1) · Dan Granoff, MD (1) · Dominique A Caugant, PhD (1) · Elizabeth Miller, BSc MBBS FFPHM FRCPath (1) · Helen Marshall (1) · Javier Diez-Domingo, PhD (1) · Manish Sadarangani, BM BCh DPhil (1) · Michaela Tinggaard, M.D. (1)
PMID 16567982, PMID 19048025, PMID 19091990, PMID 19906895, PMID 19927040, PMID 20010312, PMID 20375851, PMID 21191076, PMID 28566335, PMID 28646924, PMID 29944651, PMID 31377946, PMID 31634044, PMID 31971677, PMID 32447370, PMID 32712083, PMID 33439463, PMID 33587122, PMID 37088964, PMID 37401618, PMID 38234190, PMID 38977298, PMID 40652683
2017 (2), 2014 (1)